XJPX
9324
Market cap467mUSD
Oct 09, Last price
2,570.00JPY
1D
0.04%
1Q
4.77%
Jan 2017
239.50%
Name
Yasuda Logistics Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Yasuda Logistics Corporation, a Japanese enterprise, specializes in delivering comprehensive logistics and real estate services. Its extensive logistics operations cover a broad spectrum of offerings, from general delivery and end-to-end supply chain management to integrated solutions facilitated by its distribution centers. The company provides highly specialized medical logistics, handling pharmaceuticals, medical equipment, reagents, and diagnostic drugs, as well as dedicated IT equipment logistics that includes kitting, life cycle services, server relocation, and ongoing maintenance. Moreover, it manages archiving solutions and complete office relocation projects. Beyond its domestic services, Yasuda Logistics facilitates international trade through diverse transport options, such as ocean and air freight, import/export customs clearance, overseas logistics coordination, and offshore trade support. In its real estate division, the company offers leasing for both office and residential properties, parking services, the redevelopment and refurbishment of hotels and commercial facilities, and general building maintenance. Yasuda Logistics also engages in the sale and rental of building facilities and transportation equipment. Established in 1919 and headquartered in Tokyo, the company operated as The Yasuda Warehouse Co., Ltd. before adopting its current name, Yasuda Logistics Corporation, in June 2014.
Key people
Nobuyuki Fujii
Chairman of the Executive Board, Representative Director · since 2024
Hiroyuki Muto
Senior Managing Executive Officer, Director of International Business, Director · since 2024
Shinichiro Asano
Managing Executive Officer, Director of General Affairs, Director of Legal and Compliance · since 2025
Shingo Koizumi
Managing Executive Officer, President of Subsidiary · since 2023
Yoichi Sato
Managing Executive Officer · since 2025
Iwao Ukai
Managing Executive Officer, Director of Logistics Promotion · since 2025
Wataru Watanabe
Executive Officer, Director of 3rd Sales · since 2024
Keichi Zaitsu
Executive Officer, Director of 1st Medical Sales · since 2022
Takashi Akanuma
Executive Officer, Director of Strategic Planning · since 2023
Masayuki Arakawa
Executive Officer, Director of Accounting · since 2024
Hiroyuki Hibino
Executive Officer, Director of International Business, Chairman of Subsidiary · since 2025
Masahiko Hosoi
Executive Officer, Manager of IT Kitting Unit · since 2020
Takahisa Miwa
Executive Officer, Manager of Moriyamachi Sales Office · since 2025
Mamoru Ohara
Executive Officer, President of Subsidiary · since 2025
Hisashi Takahama
Executive Officer, President of Subsidiary · since 2023
Tadashi Matsui
Senior Managing Executive Officer, Director · since 2025
Kazunari Ogawa
Executive President, Representative Director · since 2024
Shinichi Soya
Director · since 2025
Masahiro Ifuku
Independent Director · since 2018
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||